Risk of Dialysis in Kidney Patients After Transcatheter Aortic Valve Replacement

Transcatheter aortic valve replacement (TAVR) has emerged as a viable treatment option for high-risk patients with severe aortic stenosis (AS) who are not suitable candidates for surgical aortic valve replacement (SAVR). A new study published in JACC: Cardiovascular Interventions shows that the rate of patients with chronic kidney disease (CKD) undergoing TAVR who need to start on dialysis due to kidney related issues post operation is relatively low.